{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:28:03Z","timestamp":1789450083525,"version":"build-2803163510"},"reference-count":36,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2008,10,8]],"date-time":"2008-10-08T00:00:00Z","timestamp":1223424000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>The first of several cases of meningococcal meningitis was reported in April 2005, in New Delhi, India. Subsequent to this the Government declared an outbreak, which persisted for two periods, from April\u2013July 2005 and January\u2013March 2006. The National Institute of Communicable Diseases (NICD) recommended using WHO criteria for diagnosis of disease. During the outbreak 380 clinically suspected cases were investigated. Of 55 cases diagnosed as confirmed\/probable the mortality rate was 14\u00b76%. Meningitis was reported in 60% of cases and meningococcaemia in 40%. Microscopy of petechial rash was positive in 87\u00b75%, CSF Gram stain positive in 68\u00b73%, and latex agglutination test of CSF positive in 64\u00b79% of samples.<jats:italic>Neisseria meningitidis<\/jats:italic>(serogroup A) was isolated from 37\u00b77% of cases, 57\u00b77% from CSF. Blood culture was positive in 10\u00b74% of cases. CrgA polymerase chain reaction for<jats:italic>N<\/jats:italic>.<jats:italic>meningitidis<\/jats:italic>confirmed the isolates. All isolates were susceptible to third-generation cephalosporins, azithromycin and rifampicin, with increasing resistance to ceftriaxone. Penicillin resistance was encountered in 15\u00b74% of strains. Resistance to quinolones was very high at 100% for levofloxacin, 84\u00b76% for ofloxacin and 65\u00b74% for ciprofloxacin. All patients with penicillin-resistant organisms (4) or intermediate sensitivity (4) succumbed to the disease. These patients also had a higher minimum inhibitory concentration to ceftriaxone.<\/jats:p>","DOI":"10.1017\/s0950268808001398","type":"journal-article","created":{"date-parts":[[2008,10,8]],"date-time":"2008-10-08T09:11:46Z","timestamp":1223457106000},"page":"570-576","source":"Crossref","is-referenced-by-count":36,"title":["Outbreak of meningococcal disease in and around New Delhi, India, 2005\u20132006: a report from a tertiary care hospital"],"prefix":"10.1017","volume":"137","author":[{"given":"D.","family":"NAIR","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"DAWAR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"DEB","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. R.","family":"CAPOOR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"SINGAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"UPADHAYAY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"AGGARWAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"DAS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"SAMANTARAY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2008,10,8]]},"reference":[{"key":"S0950268808001398_ref023","doi-asserted-by":"publisher","DOI":"10.1136\/adc.83.3.271"},{"key":"S0950268808001398_ref024","unstructured":"24. Canada Communicable Disease Report. Neisseria meningitidis with decreased susceptibility to penicillin in Ontario, Canada 1997\u20132000 2001; 27: 1\u20134."},{"key":"S0950268808001398_ref006","doi-asserted-by":"publisher","DOI":"10.3201\/eid1310.060820"},{"key":"S0950268808001398_ref002","first-page":"23","article-title":"Invasive meningococcal disease in the university of Malaya Medical Centre, Kuala Lumpur, Malaysia","volume":"52","author":"Raja","year":"2006","journal-title":"Journal of Postgraduate Medicine"},{"key":"S0950268808001398_ref028","first-page":"24","article-title":"An outbreak of meningitis caused by Neisseria meningitidis Group A","volume":"21","author":"Annapurna","year":"1989","journal-title":"Journal of Communicable Diseases"},{"key":"S0950268808001398_ref014","doi-asserted-by":"publisher","DOI":"10.1086\/425368"},{"key":"S0950268808001398_ref007","article-title":"Case definitions for infectious conditions under public health surveillance","volume":"46","year":"1997","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"S0950268808001398_ref022","first-page":"21","article-title":"Meningococcal disease in British Columbia","volume":"43","author":"Pollard","year":"2001","journal-title":"BC Medical Journal"},{"key":"S0950268808001398_ref020","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1128\/JCM.28.9.2134-2135.1990","article-title":"False-positive latex agglutination test for Neisseria meningitidis groups A and Y povidone-iodine antiseptic contamination of cerebrospinal fluid","volume":"28","author":"D'Amato","year":"1990","journal-title":"Journal of Clinical Microbiology"},{"key":"S0950268808001398_ref011","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1128\/JCM.34.7.1637-1640.1996","article-title":"PCR of peripheral blood for diagnosis of meningococcal disease","volume":"34","author":"Newcombe","year":"1996","journal-title":"Journal of Clinical Microbiology"},{"key":"S0950268808001398_ref008","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.11.3430-3434.2003"},{"key":"S0950268808001398_ref003","unstructured":"3. World Health Organization. Communicable Disease Department, WHO Regional Office for South East Asia. Meningococcal disease in India, Epidemic and Pandemic Alert response (EPR), CD Alert 2005."},{"key":"S0950268808001398_ref013","first-page":"547","article-title":"Meningococcal disease \u2013 outbreak in Delhi","volume":"42","author":"Sachdeva","year":"2005","journal-title":"Indian Pediatrics"},{"key":"S0950268808001398_ref018","first-page":"1","article-title":"Neisseria meningitidis meningitis","volume":"20","author":"Reger","year":"2001","journal-title":"The John Hopkins Microbiology Newsletter"},{"key":"S0950268808001398_ref015","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.13.1.144-166.2000"},{"key":"S0950268808001398_ref019","first-page":"550","article-title":"False positive latex agglutination test with Neisseria meningitidis ACYW135 in a patient with intracranial dermoid","volume":"13","author":"Erdem","year":"1994","journal-title":"Pediatrics Infectious Disease Journal"},{"key":"S0950268808001398_ref026","first-page":"249","article-title":"Sulphadiazine resistant strains of Neisseria meningitidis during an outbreak of meningococcal meningitis","volume":"85","author":"Ayyagari","year":"1987","journal-title":"Indian Journal of Medical Research"},{"key":"S0950268808001398_ref001","first-page":"585","volume-title":"Manual of Clinical of Microbiology","author":"Janda","year":"2003"},{"key":"S0950268808001398_ref010","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1128\/JCM.38.2.855-857.2000","article-title":"Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis","volume":"32","author":"Taha","year":"2000","journal-title":"Journal of Clinical Microbiology"},{"key":"S0950268808001398_ref036","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl484"},{"key":"S0950268808001398_ref009","unstructured":"9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI document (M100-S16), Vol. 26, Clinical and Laboratory Standards Institute, 2007. Wayne, Pennsylvania."},{"key":"S0950268808001398_ref030","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.Supplement_1.S98"},{"key":"S0950268808001398_ref017","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-45-1-16"},{"key":"S0950268808001398_ref031","doi-asserted-by":"publisher","DOI":"10.1159\/000007194"},{"key":"S0950268808001398_ref029","doi-asserted-by":"publisher","DOI":"10.1080\/pat.33.3.359.361"},{"key":"S0950268808001398_ref025","unstructured":"25. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI document (M100-S15) Clinical and Laboratory Standards Institute, 2005. Wayne, Pennsylvania."},{"key":"S0950268808001398_ref016","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(95)80027-1"},{"key":"S0950268808001398_ref034","doi-asserted-by":"publisher","DOI":"10.3201\/eid1106.050143"},{"key":"S0950268808001398_ref035","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.47353-0"},{"key":"S0950268808001398_ref004","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.3.1971-1973.2001"},{"key":"S0950268808001398_ref005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/0255-0857.19888","article-title":"Meningococcal disease: history, epidemiology, pathogenesis, clinical manifestations, diagnosis, antimicrobial susceptibility and prevention","volume":"24","author":"Manchanda","year":"2006","journal-title":"Indian Journal of Medical Microbiology"},{"key":"S0950268808001398_ref012","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268896007261"},{"key":"S0950268808001398_ref021","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.32.12.1222"},{"key":"S0950268808001398_ref032","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.7.3162-3171.2005"},{"key":"S0950268808001398_ref027","first-page":"1","article-title":"Meningococcal meningitis in Delhi and other areas","volume":"2","author":"Basu","year":"1985","journal-title":"Communicable Diseases Bulletin"},{"key":"S0950268808001398_ref033","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.4.1116-1116.2000"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268808001398","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T23:01:42Z","timestamp":1588978902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268808001398\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,8]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0950268808001398"],"URL":"https:\/\/doi.org\/10.1017\/s0950268808001398","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,8]]}}}